Neurocrine Biosciences
NBIXNeurocrine Biosciences is a publicly traded biopharmaceutical company founded in 1992. The company is headquartered in San Diego, California, and led by CEO Kevin Gorman. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbena …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Neurocrine Biosciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 5/5/2025 | Sell | Rastetter, William H. | Director | $110.2 | $3,305,952 |
| 2/14/2025 | Sell | Roberts, Eiry | Chief Medical Officer | $115.0 | $57,521 |
| 2/13/2025 | Sell | Abernethy, Matt | Chief Financial Officer | $116.9 | $298,923 |
| 2/13/2025 | Sell | Benevich, Eric | Chief Commercial Officer | $116.7 | $251,428 |
| 2/13/2025 | Sell | Boyer, David W. | Chief Corp. Affairs Officer | $116.7 | $208,387 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)